Design, Synthesis, and Antitumor Evaluation of an Opioid Growth Factor Bioconjugate Targeting Pancreatic Ductal Adenocarcinoma
Article in Pharmaceutics (February 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Expression heterogeneity, tumor immune characteristics and the prognosis effects of OPRL1 in patients with tumors: a pan-cancer study combined with bioinformation analyses and in vitro validation
Article in Anesthesiology and Perioperative Science (January 2024)
Pan-Cancer Analysis and Validation of Opioid-Related Receptors Reveals the Immunotherapeutic Value of Toll-Like Receptor 4
Article in International Journal of General Medicine (November 2023)